PARIS - High Flow Trials Bronchiolittis
Transcription
PARIS - High Flow Trials Bronchiolittis
How Does High Flow Treatment Work? Time for a change in Paradigm? Paediatric View of High Flow Nasal Cannula Therapy in Bronchiolitis-a PARIS High Flow Trial A/Prof Andreas Schibler University of Queensland Paediatric Critical Care Research Group (PCCRG) Lady Cilento Children’s Hospital Brisbane, QLD, Australia Objective Pressure Oxygen Work of Breathing Conflict of Interest Declaration: Swiss Precision Studies funded by National Health Medical Research Council Australia, Heart Foundation, ANZ Trustee, QEMRF, Preston James Fund, Intensive Care Foundation, Welcome Trust UK, travel expenses for conferences paid by Maquet, Draeger, Visasys, Fisher&Paykel, no personal COI Oxygen Requirement in presence of Lung Disease What does the clinician need to know? • Is a Function of Alveolar Surface - Size of the Lung, Atelectasis and Consolidation • Is a Function of Shunt Fraction - ventilation-perfusion mismatch • Is a Function of Ventilation Inhomogeneity - affected by Physiological Dead Space and preferential ventilation • Is a Function of Alveolar-Capillary Membrane - Aa-Gradient Responds to CPAP Responds to O2 1986 The Birth of High Flow 2001 Frey and Shann. Oxygen administration in infants Arch Dis Child fetal Neonatal Ed 2003;88F84-F88 2006 Saslow et al. Work of breathing using high-flow nasal cannula in preterm infants J Perinatology 2006;26:476-480 3 large RCT in preterm infants post extubation for RDS (2013) High Flow is non-inferior to nCPAP n ~ 900 infants 2015:Current intubation rate ~3-5% PICU admission fro Bronchiolitis in Australia and New Zealand Admission Rate per 100,000 700 600 500 400 300 200 100 0 1 2 3 4 5 6 7 8 9 10 Neonatal 28 days to <90 days 90 days to <1 year 1 year to <2 years 11 12 13 Risk adjusted Odds Ratio for Intubation of infants with Bronchiolitis Odds Ratio 2 1 0.5 0.25 What is High Flow Nasal Cannula oxygen therapy? • No clear definition • High Flow Nasal Cannula (HFNC) therapy is anything if: • flow rates >2L/min in infants and • flow rates ranges from 0.5 to 2L/kg/min in paediatrics • with or without fraction inspired oxygen • Maximal flow rate capped at 8L/min in the past (manufacturing limitations) • Heated and Humidified gas (undisputed benefits) • Blended oxygen Most accepted definition in bronchiolitis is: Flow rate titrated for body weight at 2L/kg/min for infants under 12mths with bronchiolitis improves lung volume, decreases electrical activity of the diaphragm and reduces WOB measured by oesophagus pressures. (Pham et al) Differences in tidal breathing between infants with chronic lung diseases and healthy controls Schmalisch BMC Pediatrics 2005 Why should we use 2L/kg/min? Table 3 Comparison of TB parameters between both patient groups ordered according to the p-value of the ANOVA (Presented are group means ± SD, statistically significant p-values after Bonferroni correction (p < 0.0028) are printed in bold) Parameter Healthy neonates (n = 48) CLD infants (n = 48) p-value CLD tI(s) RR (min-1) 0.65 ± 0.14 39.2 ± 8.6 0.45 ± 0.11 55.4 ± 14.2 p < 0.0001 p < 0.0001 (PTIF+PTEF)/VT (s-1) 0.27 ± 0.06 0.37 ± 0.09 p < 0.0001 tE (s) VT/tI(mL·s-1·kg-1) 0.98 ± 0.24 8.9 ± 2.2 0.72 ± 0.22 11.6 ± 2.8 p < 0.0001 p < 0.0001 V'E(mL·min-1·kg-1) 215 ± 51.7 276 ± 76.8 p < 0.0001 TIF 50 (L·min-1·kg-1) 0.75 ± 0.21 0.98 ± 0.26 p < 0.0001 PTIF (L·min-1·kg-1) 0.83 ± 0.20 1.05 ± 0.28 p < 0.0001 5.25 ± 3.66 1.05 ± 0.28 p =p0.0001 < 0.0001 0.64 ± 0.19 0.82 ± 0.29 p = 0.0006 -1-2·kg-1-1 PTEF/t )) PTEF (L·s·kg PTIF (L·min PTEF (L·min-1·kg-1) tptef (s)*) 2.90±± 0.20 1.68 0.83 0.24 ± 0.09 0.18 ± 0.11 p = 0.001 TEF75 (L·min-1·kg-1) 0.60 ± 0.20 0.76 ± 0.29 p = 0.003 TEF50 (L·min-1·kg-1) 0.52 ± 0.17 0.66 ± 0.25 p = 0.003 TEF25 (L·min-1·kg-1) 0.38 ± 0.11 0.46 ± 0.16 p = 0.006 Vptef (mL/kg)*) VT (mL·kg-1) VPTEF/VT(%)*) tPTEF/tE (%)*) 1.68 ± 0.52 5.57 ± 1.06 29.4 ± 6.6% 25.8 ± 9.7% 1.37 ± 0.44 5.15 ± 1.35 27.2 ± 6.1% 23.2 ± 7.8% p = 0.006 p = 0.09 p = 0.13 p = 0.20 *)Loops with flow limitations, grunting or other deformations were excluded from the evaluation (6 controls, 8 CLD infants) Abbreviations: tI,E-inspiratory, expiratory time, RR-respiratory rate, PTIF, PTEF-peak tidal inspiratory and expiratory flow, VT-tidal volume, TIF 50-tidal inspiratory flow when 50% of VT is inspired, TEF 75, TEF 50, TEF 25-expiratory flow when 75%, 50% and 25% of tidal volume remains in the lung, V' E-minute ventilation, tPTEF,VPTEF-time and volume to peak tidal expiratory flow Schmalisch et al. BMC Pediatrics 2005 5:36 doi:10.1186/1471-2431-5-36 Physiological Evidence Plausible cause relationship of High Flow Pharynx Pressure PEEP Milesi C. Intensive Care Med 2013 ~ 1.6 L/kg/min Inspiratory Aid High Flow Setup 2 L/kg/min Blended O2/Air Heated, Humidified Infant Oxygen Cannula BC2745 HFNC during interhospital Transport children < 2 years of age Figure 1: High-flow nasal prong system used for retrievals of critically ill children. 1, nasal cannulae; 2, distal temperature probe; 3, tubing; 4, heated humidifier, 5, oximeter, 6, flow-meter with ventouri blender, 7, ambient air entry port through air filter, 8, Pressurized O 2 access How does HFNC compare to CPAP? Early Intervention Intubation – Ventilation - Pressure Injury Doing less Surfactant plus Ventilation Surfactant plus CPAP CPAP 32-36 weeks 26-32 weeks 23-24 gestational week survival on CPAP only Neonatal Respiratory Distress Research Delivery Room Neonatal Intensive Care Unit Progression of Disease Acute Respiratory Distress Research Progression of Disease Emergency Department Operating Theatre Hospital Ward Intensive Care Unit Acute Respiratory Distress Research Progression of Disease Emergency Department Operating Theatre Hospital Ward Intensive Care Unit Primary Outcome Study Protocol Responder HFNC 2L/kg/min Inclusion Criteria * Bronchiolitis * SpO2 <92/94%% * < 12mths Transfer Non-Responder Responder Control Responder Non-Responder HFNC 2L/kg/min Non-Responder Criteria for non-responder: RR, HR and EWT unchanged after 120-180 min Transfer CPAP WOB FiO2 Control Humidification Standardization Evidence - + ACKNOWLEDGMENTS Collin Myers PARIS Study Group Donna Franklin Sue Moloney Tom Hurley David Levitt Marlon Radcliffe Vishal Kapoor John Waugh John Coghlan John Gavranich David McMaster Jan Cullen Luregn Schlapbach Christian Stocker Adrian Mattke Lee O’Malley Trang Pham Geraldine Corcoran Debbie Long Tara Williams Kimble Dunster John Fraser Tom Riedel PREDICT Study Group Stuart Dalziel Franz Babl Ed Oakley Jocelyn Neutze Simon Craig Kam Sinn Jeremy Furyk Natalie Phillips Inclusion Criteria: 1. Infants < 12 mths (corrected age) requiring admission to your hospital 2. Diagnosed with Bronchiolitis (viral illness characterised by coryzal symptoms for 1-3days, then worsens on days 3-5, with increased work of breathing and auscultatory findings of possible crackles and wheeze) 3. Oxygen requirement with SpO2 <94% in room air If oxygen in ambulance - turn off briefly to assess SpO2 in room air. Exclusion criteria: • Upper airway obstruction • Apnoeas • Craniofacial malformation • Critically ill and immediate need for Intubation and Ventilation or NIV • Basal skull Fracture • Trauma • Decreased level of consciousness • Cyanotic Heart Disease • Home Oxygen therapy